跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-AMLODIPINE TABLET 5MG - HSA Drug Approval Details
Approvals
/
HSA
/
APO-AMLODIPINE TABLET 5MG
Approved
THERAPEUTIC
APO-AMLODIPINE TABLET 5MG
APOTEX INC. (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Jun 18, 2012
Approval ID
ed497d5b7ae8b0f8
Company
APOTEX INC. (CANADA)
Type
Therapeutic
Approval Details
Approval Id
ed497d5b7ae8b0f8
Drug Name
APO-AMLODIPINE TABLET 5MG
Product Name
APO-AMLODIPINE TABLET 5MG
Approval Number
SIN14159P
Approval Date
2012-06-18
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
C08CA01
Atc Item Name
amlodipine
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
Amlodipine Besylate 7mg eqv to Amlodipine
5.0mg
AMLODIPINE BESYLATE 7 MG EQV TO AMLODIPINE
5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 18, 2012
Approval ID
ed497d5b7ae8b0f8
Type
Therapeutic
Back to HSA Approvals